ResDAC is currently experiencing a high volume of requests, which may delay response and processing times. We are working to address the backlog as quickly as possible and appreciate your patience.
This variable is contained in the following files:
SAS Name
HER2_AMPLIFICATION
HER2 amplification.
Source: Oncology Care Model Data Registry
| Code | Code value |
|---|---|
| None Selected | |
| Not Tested | |
| Equivocal | |
| Negative | |
| Positive | |
| Null/missing | n/a (not breast gastro/esophageal cancer); or not reported by OCM participant (reference details in the RPTD_TO_RGSTRY codebook entry) |
Practices were required to report clinical and staging data associated with each beneficiary’s assigned cancer. HER2 Amplification is routinely tested for breast cancer and gastro/esophageal cancer. It is necessary for breast cancer staging and helps determine treatment decisions. This variable is only populated for episodes with breast cancer or gastro/esophageal cancer.